The government launched the first phase of the pharmacare program last year, which provides what it calls ‘universal, single-payer, first-dollar coverage’ of contraceptives and some diabetes medications at little or no cost to patients.
Study assesses the safety and efficacy of canagliflozin in children and adolescents with type 2 diabetes who are inadequately controlled on metformin and/or insulin.
Released Thursday, the template lays out definitions of key entities and suggests regulations surrounding patient choice, prohibition of interference in the pharmacist-patient relationship, transaction fees audits and more.
Canadian study examines QT-interval prolonging drug interactions with fluoroquinolones in older women with uncomplicated urinary tract infections in long-term care.
Salaried pharmacists expressed concerns about the increase in clinical responsibilities with Bill 67, while already experiencing a workload deemed excessive in an increasingly pressured environment.
The quality of entries for our 2025 Student Essay Contest was so high that we decided to share them all. Here's an essay by Amy Margaret Maclean from the University of Ottawa.
